Auro Labs.

28
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE292C01011
  • NSEID:
  • BSEID: 530233
INR
247.60
5.9 (2.44%)
BSENSE

Nov 20

BSE+NSE Vol: 2.9 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 60.74% vs -64.34% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 219.80% vs -70.68% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 292.91% vs 47.13% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 92.14% vs -76.40% in Mar 2025

Compare Profit and Loss Results of Auro Labs.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
30.00
206.00
-176.00
-85.44%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
30.00
206.00
-176.00
-85.44%
Expenditure (Ex Depriciation)
Stock Adjustments
-8.00
-1.00
-7.00
-700.00%
Raw Materials Consumed
14.00
153.00
-139.00
-90.85%
Power & Fuel Cost
1.00
3.00
-2.00
-66.67%
Employee Cost
5.00
7.00
-2.00
-28.57%
Operating Expenses
0.00
11.00
-11.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
8.00
-6.00
-75.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
1.00
0.00
0.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
20.00
189.00
-169.00
-89.42%
Operating Profit (PBDIT) excl Other Income
10.00
17.00
-7.00
-41.18%
Other Income
2.00
5.00
-3.00
-60.00%
Operating Profit (PBDIT)
12.00
22.00
-10.00
-45.45%
Interest
4.00
1.00
3.00
300.00%
Profit before Depriciation and Tax
7.00
21.00
-14.00
-66.67%
Depreciation
2.00
3.00
-1.00
-33.33%
Profit Before Taxation & Exceptional Items
4.00
18.00
-14.00
-77.78%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
4.00
18.00
-14.00
-77.78%
Provision for Tax
1.00
4.00
-3.00
-75.00%
Profit After Tax
3.00
13.00
-10.00
-76.92%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
35.00
42.00
-7.00
-16.67%
Profit Available for appropriations
39.00
55.00
-16.00
-29.09%
Appropriations
39.00
55.00
-16.00
-29.09%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
5.67
1.58
4.09
258.86%
Profit And Loss - Net Sales
Net Sales 30.74 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 60.74% vs -64.34% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.01 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 219.80% vs -70.68% in Mar 2025

Profit And Loss - Interest
Interest 4.25 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 292.91% vs 47.13% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 3.53 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 92.14% vs -76.40% in Mar 2025